Global /Türkiye /Healthcare /Drug Manufacturers - General /DEVA
chevron_leftBack
Deva Holding A.S. logo

Deva Holding A.S.

DEVA
IST: DEVA Delayed
66.30TRY -1.8%
1.44 USD
As of 5 June 2026, Deva Holding A.S. has a market cap of $293.69M USD, ranking #18713 globally and #199 in Türkiye. It ranks #1697 in the Healthcare sector, and #619 in the Drug Manufacturers - General industry.
Global Rank
18713
Country Rank
199
Sector Rank
1697
Industry Rank
619
Key Stats
Market Cap
$293.69MUSD
13.5B TRY
Enterprise Value
$345.68MUSD
15.89B TRY
Revenue (TTM)
$418.65MUSD
19.25B TRY
EBITDA (TTM)
$33.59MUSD
1.54B TRY
Net Income (TTM)
-$17.55MUSD
-806.99M TRY
EBITDA Margin
8%
Profit Margin
-4.2%
PS Ratio
0.7
PB Ratio
0.5
EV/EBITDA
10.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Philipp Haas open_in_new
Employees
3,023
Founded
1958
Website
deva.com.tr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.8% -1.7% 11% -1.2% -5% 16%

News

Loading...

Markets

Exchange Ticker Price
Borsa Istanbul
MIC: XIST
PRIMARY
DEVA
DEVA HOLDİNG A.Ş.
ISIN: TRADEVAW91E2
Shares Out.:
199.99M1 Shares Float: 35.589M2
TV:
SA:
YF:
GF:
BA:
MS:
66.30 TRY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Deva Holding A.S.

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; systemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary systems, connective tissue, and sensory organs. In addition, the company offers various products in sterile and non-sterile forms, including liquids, semi-solids, solids, cephalosporins, penicillin, hormone and inhalation products, solid and liquid oncology, animal health products, active pharmaceutical ingredients, ampoules, liquid and lyophilized vials, eye drops, and medical ampoules for sterile injectable products, as well as cologne. It also exports its products to approximately 60 countries. The company was incorporated in 1958 and is based in Istanbul, Turkey. Deva Holding A.S. is a subsidiary of Eastpharma S.à R.L.

Similar Companies

Industry: Drug Manufacturers - General (Türkiye)
Name
Market Cap diff.
PE
$1.28B
58.69B TRY
335%
28.1
$946.57M
43.52B TRY
222%
63.7
$149.42M
6.87B TRY
-49%
136.3
$80.31M
3.69B TRY
-73%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
259K%
38.1
JNJ
$547.28B
186K%
26.4
ABBV
$360.63B
123K%
97.4
$324.68B
256.25B CHF
110K%
19.9
AZN
$289.43B
215.59B GBP
98K%
27.6
NOVN
$277.35B
218.9B CHF
94K%
20.5
chevron_leftBack